ArticleExperimental & molecular medicine2023

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation.

Jin Wook Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.